Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
March 18, Sunday 2018 11:37 AM       

       HEADLINES: Two workers killed in accident                                              LPG tanker lorry overturns in Malappuram                                              Congress won’t cower in front of Modi’s arrogance: Sonia Gandhi                                              Stalin supports ‘Dravida Nadu’                                              Bhawana Kanth becomes second Indian woman fighter pilot to go solo                                              Student faces suspension for not taking part in gun violence walkout                                              Pak PM discusses Afghan peace process with US VP                                              Trump re-affirms plan to meet Kim Jong Un                                              Pak to skip WTO meet in New Delhi                                              India advanced in 30 years as much as Britain did in 150: Paul Krugman                                              IPL 2018: Pune to host two play-off matches                                              KP confirms retirement in heartfelt Instagram post                                              All England Open: Sindhu eyes final berth                                              Kaumudi Facebook
       SCI&TECH Next Article: Clearing the myths about osteoporosis  
       Aspirin a day may keep liver cancer away
         Posted on :18:27:33 Oct 21, 2017
       Last edited on:18:27:33 Oct 21, 2017
         Tags: Aspirin a day may keep liver cancer away

WASHINGTON DC: Taking aspirin daily can reduce the risk of liver cancer, a new study suggested.

The researchers found that everyday aspirin therapy could significantly associate with a reduced risk in hepatitis B related liver cancer.

Hepatitis B is a viral infection that attacks the liver. HBV can be contracted through contact with an infected person's blood or other bodily fluid, and the infection can either be acute or chronic.

It has been estimated that around estimated 240 million people worldwide have chronic HBV. The findings also show Africa and Asia as the highest prevalence of the virus.

Previous studies also show that daily aspirin therapy -- which is often prescribed to prevent cardiovascular disease -- may also prevent the development of cancer.

However, on another note clinical evidence is being lacked for the effectiveness of aspirin therapy in preventing HBV-related liver cancer.

Researcher Teng-Yu Lee from the Taichung Veterans General Hospital conducted a nationwide cohort study to determine if aspirin therapy could, indeed, reduce liver cancer risk.

"Liver cancer is the second leading cause of cancer death worldwide, and HBV is the most prevalent risk factor in our region," said Dr. Lee who's the lead author of the study.

"HBV-related liver cancer is therefore a major public health issue with a severe socioeconomic impact," he stated.

Dr. Lee stated that therapies which reduce the risk of liver cancer like, nucleos(t)ide analogue therapy, do not completely eliminate the risk. Adding, he also mentioned that most HBV carriers are not indicated for antiviral therapy, so another effective way of reducing liver cancer risk needs to be developed.

"Aspirin has been investigated to explore its chemopreventive effect in cancers that are related to chronic inflammation, particularly in the prevention of colorectal cancer. However, clinical evidence supporting the chemopreventive effect of aspirin therapy on liver cancer remains limited. Therefore, we conducted a large-scale cohort study to evaluate the association of aspirin therapy with HBV-related liver cancer," he noted.

Retrieving past medical records for the study, they screened records of 204,507 patients with chronic hepatitis B, and excluded patients with other forms of infectious hepatitis, from the National Health Insurance Research Database between the year 1998 and 2012.

The past findings showed that 1,553 patients who continuously received daily aspirin for at least 90 days were randomly matched 1:4 with 6,212 patients who had never received anti- platelet therapy by means of propensity scores consisting of baseline characteristics.

The researchers analyzed both cumulative incidents of and hazard ratios for HCC development after adjusting for competing mortality.

Cumulative incidence of liver cancer in the group treated with aspirin therapy was significantly lower than that in the untreated group in five years.

The researchers in their multivariate regression analysis found that aspirin therapy was independently associated with reduced liver cancer risk.

"For effectively preventing HBV-related liver cancer, the findings of this study may help hepatologists treat patients with chronic HBV infection in the future, particularly for those who are not indicated for antiviral therapy. We are pursuing prospective investigations for further confirming the findings," stated Dr. Lee.

The study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases (AASLD).

Next Article: Clearing the myths about osteoporosis
New habitable planet found near our solar system  
Going light with the new Light Phone 2  
What will happen to this beautiful blue planet?  
Liver cancer: New method identifies splicing biomarkers  
Astronomers reveal secrets of most distant supernova ever detected  
Ensuring sexual, reproductive health for overall well-being  
WeChat gets popular in Bhutan: report  
Celebrate love this Valentine's Day with Google Pixel 2  
This drug could reverse alcohol's damaging effects on brain  
Scientists discover enormous reserves of mercury in permafrost  
Google Assistant helps you set music alarms  
What is epilepsy?  
Here're some ways to keep dementia at bay  
What are memories made of?  
Second-hand plastic toys could harm your kid  
Working before and after stroke is good for brain health  
ixigo introduces India's first augmented reality feature for Train Passengers  
Super blue moon on Jan. 31 will mark last of trilogy  
Now, a blood test that can screen eight cancer types  
Secret of longevity protein revealed!  
Absence of this gene can give men deadly cancer  
Soon, you can demote group admins on WhatsApp  
Regular yoga can slow down ageing of brain: Study  
What are haemorrhoids (piles) and what causes them?  
WhatsApp facilitates quick switch from voice to video call  
Do you think controversies are now being used as business tools?
don't opinion
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy